Projects

As an example, here are numerous current clinical examinations being conducted by the study center: 

• OnTarget
  In this multicentral, multinational endpoint study the effectiveness of the angiotensin-receptor blocker Telmisartan® will be tested in the event of a cardio and cerebrovascular occurrence in risk persons 
• Charisma
  This multicentral und multinational study tests the effects of thrombocyt aggregation inhibitor in the event  of a cardio and cerebrovascular endpoint
• TREAT
  This multicentral and multinational Phase III-study investigates the effects of anemia therapy in regard to not only the entire mortality, but also in the event of a cardiovascular occurrence in patients with coronary heart disease and Type 2 Diabetes mellitus
• MedTech-Studies
  At the Diabetes Center Mergentheim evaluations of medical innovations are constantly taking place, with an emphasis on diabetes relevance

Print